124 related articles for article (PubMed ID: 20969626)
1. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
Soares AB; de Araújo VC; Juliano PB; Altemani A
J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
[TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
4. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Altemani A; de Araújo VC
Histopathology; 2011 Feb; 58(3):377-82. PubMed ID: 21323961
[TBL] [Abstract][Full Text] [Related]
5. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
[TBL] [Abstract][Full Text] [Related]
6. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.
Stennert E; Wittekindt C; Klussmann JP; Arnold G; Guntinas-Lichius O
Laryngoscope; 2004 Jan; 114(1):158-63. PubMed ID: 14710014
[TBL] [Abstract][Full Text] [Related]
7. [Recurring tumors of the parotid gland with special reference to pleomorphic adenoma].
Ott PM; Grob U
Schweiz Med Wochenschr; 1982 May; 112(21):757-60. PubMed ID: 6285455
[TBL] [Abstract][Full Text] [Related]
8. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
Mann W; Beck C; Karatay MC
Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
10. [Recurrence tendency and malignant transformation of pleomorphic adenomas].
Chilla R; Schneider K; Droese M
HNO; 1986 Nov; 34(11):467-9. PubMed ID: 3027008
[TBL] [Abstract][Full Text] [Related]
11. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44V6 in parotid pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Yang S; Wang HP; Wang XY; Guo LJ; Tang XF; Gao QH; Xuan M; Loo WT; Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S101-8. PubMed ID: 20374021
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
[TBL] [Abstract][Full Text] [Related]
15. [Pleomorphic parotid adenomas and their recurrence].
Federspil PA; Federspil P; Schätzle W
HNO; 1994 Jan; 42(1):28-35. PubMed ID: 8150670
[TBL] [Abstract][Full Text] [Related]
16. Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle.
Marioni G; Marino F; Stramare R; Marchese-Ragona R; Staffieri A
Head Neck; 2003 Dec; 25(12):1071-6. PubMed ID: 14648866
[TBL] [Abstract][Full Text] [Related]
17. Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.
Kinoshita I; Jin D; Higashino M; Terada T; Kurisu Y; Takai S; Kawata R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884420
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pleomorphic adenoma of the parotid gland: A population-based study with emphasis on re-recurrence and malignant transformation.
Xu W; Zhang X; Wu Y; Zhu Y; Liu S; Lu H; Yang W
Head Neck; 2023 Mar; 45(3):697-705. PubMed ID: 36563305
[TBL] [Abstract][Full Text] [Related]
19. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
20. Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.
Patel RS; Hughes CW; Fredericks S; Lee CS; Rose B; Gao K; Smith G; Hong A; O'Brien CJ
Histopathology; 2007 Jul; 51(1):21-5. PubMed ID: 17593077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
